These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 19562708)
1. Aprotinin and the risk of thrombotic complications after liver transplantation: a retrospective analysis of 1492 patients. Warnaar N; Mallett SV; Klinck JR; de Boer MT; Rolando N; Burroughs AK; Jamieson NV; Rolles K; Porte RJ Liver Transpl; 2009 Jul; 15(7):747-53. PubMed ID: 19562708 [TBL] [Abstract][Full Text] [Related]
2. Bleeding in cardiac surgery: the use of aprotinin does not affect survival. Pagano D; Howell NJ; Freemantle N; Cunningham D; Bonser RS; Graham TR; Mascaro J; Rooney SJ; Wilson IC; Cramb R; Keogh BE J Thorac Cardiovasc Surg; 2008 Mar; 135(3):495-502. PubMed ID: 18329459 [TBL] [Abstract][Full Text] [Related]
3. [Reduction of blood loss in orthotopic liver transplantation with the use of aprotinin]. Légaré G; Roy A; Dagenais M; Lapointe R; Marleau D; Thuot C Ann Chir; 1996; 50(8):601-5. PubMed ID: 9035431 [TBL] [Abstract][Full Text] [Related]
4. High incidence of thrombotic complications early after liver transplantation for familial amyloidotic polyneuropathy. Bispo M; Marcelino P; Freire A; Martins A; Mourão L; Barroso E Transpl Int; 2009 Feb; 22(2):165-71. PubMed ID: 18699846 [TBL] [Abstract][Full Text] [Related]
5. Hepatic artery thrombosis after orthotopic liver transplantation. Abou Ella KA; Al Sebayel MI; Ramirez CB; Rabea HM Saudi Med J; 2001 Mar; 22(3):211-4. PubMed ID: 11307104 [TBL] [Abstract][Full Text] [Related]
7. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not a prothrombotic, effect. Molenaar IQ; Legnani C; Groenland TH; Palareti G; Begliomini B; Terpstra OT; Porte RJ Liver Transpl; 2001 Oct; 7(10):896-903. PubMed ID: 11679989 [TBL] [Abstract][Full Text] [Related]
8. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis. Guzzetta NA; Evans FM; Rosenberg ES; Fazlollah TM; Baker MJ; Wilson EC; Kaiser AM; Tosone SR; Miller BE Anesth Analg; 2009 Feb; 108(2):448-55. PubMed ID: 19151271 [TBL] [Abstract][Full Text] [Related]
9. Hepatic artery complications after orthotopic liver transplantation: interventional treatment or retransplantation? Yang Y; Li H; Fu BS; Zhang Q; Zhang YC; Lu MQ; Cai CJ; Xu C; Wang GS; Yi SH; Zhang J; Zhang JF; Yi HM; Jiang N; Jiang H; Zhu KS; Jiang ZB; Shan H; Chen GH Chin Med J (Engl); 2008 Oct; 121(20):1997-2000. PubMed ID: 19080263 [TBL] [Abstract][Full Text] [Related]
10. Effects of aprotinin dosage on renal function: an analysis of 8,548 cardiac surgical patients treated with different dosages of aprotinin. Dietrich W; Busley R; Boulesteix AL Anesthesiology; 2008 Feb; 108(2):189-98. PubMed ID: 18212563 [TBL] [Abstract][Full Text] [Related]
11. Aprotinin and nafamostat mesilate in liver surgery: effect on blood loss. Pereboom IT; de Boer MT; Porte RJ; Molenaar IQ Dig Surg; 2007; 24(4):282-7. PubMed ID: 17657153 [TBL] [Abstract][Full Text] [Related]
12. Incidence of prolonged length of stay after orthotopic liver transplantation and its influence on outcomes. Smith JO; Shiffman ML; Behnke M; Stravitz RT; Luketic VA; Sanyal AJ; Heuman DM; Fisher RA; Cotterell AH; Maluf DG; Posner MP; Sterling RK Liver Transpl; 2009 Mar; 15(3):273-9. PubMed ID: 19243008 [TBL] [Abstract][Full Text] [Related]
13. Aprotinin does not increase the risk of renal failure in cardiac surgery patients. Furnary AP; Wu Y; Hiratzka LF; Grunkemeier GL; Page US Circulation; 2007 Sep; 116(11 Suppl):I127-33. PubMed ID: 17846292 [TBL] [Abstract][Full Text] [Related]
14. Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors. Paugam-Burtz C; Kavafyan J; Merckx P; Dahmani S; Sommacale D; Ramsay M; Belghiti J; Mantz J Liver Transpl; 2009 May; 15(5):522-9. PubMed ID: 19399736 [TBL] [Abstract][Full Text] [Related]
15. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial. Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838 [TBL] [Abstract][Full Text] [Related]
16. Orthotopic liver transplantation without venovenous bypass: 125 cases from a single center. Miranda LE; de Melo PS; Sabat BD; Tenório AL; Lima DL; Neto OC; Amorim AG; Fernandez JL; de Macedo FI; Lacerda CM Transplant Proc; 2012 Oct; 44(8):2416-22. PubMed ID: 23026610 [TBL] [Abstract][Full Text] [Related]
17. Cigarette smoking is associated with an increased incidence of vascular complications after liver transplantation. Pungpapong S; Manzarbeitia C; Ortiz J; Reich DJ; Araya V; Rothstein KD; Muñoz SJ Liver Transpl; 2002 Jul; 8(7):582-7. PubMed ID: 12089709 [TBL] [Abstract][Full Text] [Related]
18. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass. Manrique A; Jooste EH; Kuch BA; Lichtenstein SE; Morell V; Munoz R; Ellis D; Davis PJ Anesth Analg; 2009 Jul; 109(1):45-52. PubMed ID: 19535694 [TBL] [Abstract][Full Text] [Related]
19. Prediction of cardiac complications after liver transplantation. Fouad TR; Abdel-Razek WM; Burak KW; Bain VG; Lee SS Transplantation; 2009 Mar; 87(5):763-70. PubMed ID: 19295324 [TBL] [Abstract][Full Text] [Related]
20. Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients. Duffy JP; Hong JC; Farmer DG; Ghobrial RM; Yersiz H; Hiatt JR; Busuttil RW J Am Coll Surg; 2009 May; 208(5):896-903; discussion 903-5. PubMed ID: 19476857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]